DataSheet_2_IKZF1plus is a frequent biomarker of adverse prognosis in Mexican pediatric patients with B-acute lymphoblastic leukemia.docx by Joaquin Garcia-Solorio (18296686)

“…</p>Results<p>We identified the IKZF1^plus profile in 21.8% of patients, which was higher than that previously reported in other studies. A significantly older age (p=0.04), a trend toward high-risk stratification (p=0.06), and a decrease in 5-year Overall Survival (OS) (p=0.009) were observed, although heterogeneous treatment protocols in our cohort would have impacted OS. …”

DataSheet_1_IKZF1plus is a frequent biomarker of adverse prognosis in Mexican pediatric patients with B-acute lymphoblastic leukemia.xlsx by Joaquin Garcia-Solorio (18296686)

“…</p>Results<p>We identified the IKZF1^plus profile in 21.8% of patients, which was higher than that previously reported in other studies. A significantly older age (p=0.04), a trend toward high-risk stratification (p=0.06), and a decrease in 5-year Overall Survival (OS) (p=0.009) were observed, although heterogeneous treatment protocols in our cohort would have impacted OS. …”

Changes in work exposure as a function of relative time for seven fixed values of mean exposure. by Danuta Roman-Liu (8532645)

Voxel representation of a 3D binary image (left) and its corresponding graph of connected pore space voxels (right). by Mouad Klai (20818364)

Identification of 5-FU-sensitizing genes. by Tomohiko Sakabe (282459)

“…<p>(A) Determination of a 5-FU concentration sufficient to decrease cell viability in HepG2 cells, which were treated with various concentrations of 5-FU for 72 h. …”

Chemical and siRNA-mediated inhibition of catalase activity in A549 cells enhances the cytotoxic effects of heme. by Lilibeth Lanceta (782925)

A model with two target-cell populations and viral competition in one of these populations matches <i>in vivo</i> data and predicts that R5 inhibitors accelerate AIDS onset. by Ariel D. Weinberger (169848)

“…(D) Time-dependency of X4 emergence as a function of CCR5 inhibitor efficacy (α-CCR5 efficacy) in the “competitive regime.” …”

CMR, CATH, CFD, and LP data for the left and right lungs, comparing (a) mean indexed flow rates and (b) mean pressures. by Sebastian Laudenschlager (19233101)

Primers sequences for qRT-PCR. by Peiguang Niu (17044532)

“…Free fatty acids (FFA) was measured by fluorescence using acyl-CoA oxidation and carnitine palmitoyl transferase-1 (CPT-1) activity was analyzed by spectrophotometric assay using palmitoyl-CoA and DTNB (5,5’-dithio-bis-(2-nitrobenzoic acid)) reaction. mRNA expression was measured by Quantitative Real-Time PCR. …”

Original western blotimages. by Peiguang Niu (17044532)

“…Free fatty acids (FFA) was measured by fluorescence using acyl-CoA oxidation and carnitine palmitoyl transferase-1 (CPT-1) activity was analyzed by spectrophotometric assay using palmitoyl-CoA and DTNB (5,5’-dithio-bis-(2-nitrobenzoic acid)) reaction. mRNA expression was measured by Quantitative Real-Time PCR. …”

Original data. by Peiguang Niu (17044532)

“…Free fatty acids (FFA) was measured by fluorescence using acyl-CoA oxidation and carnitine palmitoyl transferase-1 (CPT-1) activity was analyzed by spectrophotometric assay using palmitoyl-CoA and DTNB (5,5’-dithio-bis-(2-nitrobenzoic acid)) reaction. mRNA expression was measured by Quantitative Real-Time PCR. …”

E10.5 FVB/N KLF2−/− hearts have abnormal cardiac jelly, and a reduction in transformed mesenchymal cells. by Aditi R. Chiplunkar (282141)

“…(<b>E</b>) qRT-PCR indicates a 2-fold decrease in expression of Ugdh mRNA (p = 0.0204) in FVB/N KLF2−/− but not mix KLF2−/− compared to WT AV region (n = 7). …”

Table_5_The Advantage of Supine and Standing Heart Rate Variability Analysis to Assess Training Status and Performance in a Walking Ultramarathon.DOCX by Martina Anna Maggioni (8568585)

“…Twenty-five competitors in a 100 km walking ultramarathon underwent pre-race supine (12 min) and standing (6 min) HR recordings, whereas performance and subjective training experience were assessed post-race. …”

Cardamonin inhibited the activation of mTORC1 and protein expression of Raptor. by Peiguang Niu (17044532)

Cardamonin inhibited the proliferation of ovarian cancer cells. by Peiguang Niu (17044532)

Cardamonin inhibited the proliferation of ovarian cancer cells. by Peiguang Niu (17044532)

Cardamonin inhibited the activation of mTORC1 and protein expression of Raptor. by Peiguang Niu (17044532)

Changes in the SF change rate every 10 s in Experiment 2. by Hiroaki Furukawa (14341649)

“…<p>The error bars represent between-participant SD. Both +5bpmFS (C) and -5bpmFS (D) showed a tendency to decrease, reproducing the results of Experiment 1. …”

Time series trends showing six-month retention and six-month mortality for cohorts enrolled in each month from January 2015 through December 2018 comparing pre-UTT (2015–2016) and... by Levicatus Mugenyi (6393749)

Image 5_Presurgical molecular therapy for renal cell carcinoma with venous tumor thrombus: a systematic review and meta-analysis.jpeg by Kewei Chen (298512)

“…</p>Results<p>Overall, 184 patients were enrolled in this study. 30.7% (95% CI, 17.6–43.8%, I² = 79%, p<0.01) patients experienced a decrease in TT levels after receiving PMT, while only 1.5% (95% CI, 0–0.044%, I² = 0%, p=0.98) exhibited an increase in TT levels. …”